mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.004 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.006 |